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L1067-2o I ~lvemms of Maxe Procedure for  Patients With 
Giant Left Mdum Auoc la te~ With Mltral Valvular 
Olemme 
~, Ynda, S, Nskat~ni, M, Yamagmhi, Y. Kosakat, K. Miyatsko, Na/~al 
C a ~ r  C~r .  Osaka, Japan 
Backgro~d: Anhough 111o Maze I:)f~coduro ~ boon eff~:ti~ ~ restore 
sinus dlylllm in mo~ pat~mt~ wlth chmn~ atrial fibrillation (At). it is unknown 
whe~u" th~ procedure I~ offe~ivo !of m~o,ng sig~flcant el,a! conti'a~tion 
e~m in pati4m1~ with ~ loft alflum (GLA}. 
Mett~o¢~ We echo~z~tograp~lly ~ m pat~mt~ w~ OLA tO(*), 
~,  S~ • 11 y~w~) a~ 32 pat~m without GLA (O(~), ~ ,  SS • O 
yearn, p ~, NS) ~ nnd ~fte~ su~ry. (mean, 2.5 :~ 2,5 n~th~), '1~ 
I~ak velocity (Av, ~)  and un~ vek~ty ~ (A,, cm) of Im diasto~ 
filling ~ve  (A,wave) were memluet~l from Wanmmmal f ow ~on~g~, At.al 
~ frac~on (AFF, %) was caJcu~ated em n fmctm~ Of AJ to t~me-vek~cW 
integrnl of total dictate fdl~, Wo c~ddm~ 1~ ~ o! p wave in 
EGG incJaating ~ atnai elecln~ ~¢I~v and Av morn man I0 c,n~ 
in~a~ ~ atf~ mechamcaz a~ty .  
,qew.~s: 
G|*~ a t4~} 4 (21%) 9 (4T%) 5.2 ~ 24 5 t o IR z 6 
G| - ) ;~7 (~4%) 2! (l~%l 4113%) 4.% z 14 5 x 2 16 x 4 
• ool ~o0t .0Ol NS NS NS 
~ - 1 )  Reslrahon at electncal aWial ~ was more frequem 
than that of me¢~ atrial activity. 2) Almo~gl'~ most patents wm'~out GLA 
~ s~nmcanZ ~ and ~ ~ by me Maze Woce- 
dum, lewer patients ,~h GLA could restore bolh ol IJt~m. 3) However, once 
~F~cent actwe Cont r~ ~ m~med, the degnm at centrac1~ was 
cemparabfa belween patients wdh and wdhoul GLA. 4) The Maze pmce(tum 
mav be worth trying m patmnts with GLA. 
• Fen l lmmine  Combination Therapy for Obesity: 
The Appearance Rate o f  Amlk :  Regurgitation on 
Serial Echoes Parallels the Incidence in a 
Cohort  PoputaUon 
GE Sander, D.H. Ryan, G.A. Bray, F.L Greenway, E.K. Kerut. T.D G*~=s. 
Pernngmn/l~med~ca! tnsmute~ BO~on Rouge,/_4, and L~U Medaa~ 
Ce.~er. New Orleans. ~ U.~; 
Background: Fenflmamme is used fo treat obesity, most often in cem~nation 
wzth pl~ntern~no (ten/l~=n), but also alone or with maZ~loi (fen,~xmz)~ 
Fen/phen has recenlty been associated with an unusual thicker~g o! right- 
and left-sided heart valves and valvular egurgitat~n (VR)+ This Is the iz~Iral 
repo~ Of serial changes by ech0cmdiogram-Doplder tED) ~ and of the 
prevalence of VR in a well-Oat!ned, systemabcalty treated cohort. 
Me/ho~- Since 1994. 242 patients r~cetved fan/phen and or fen/maz for 
at least six months: 48 had baseline EO studies before treatment Thus far. 
137 of the total cohort have beo"t m-studied by ED. Both color S,'xI continu- 
ous wave findings, confirmed I~ two echecardiogrephers, were required to 
estabhsh VR. 
Results: Two out o! 17 (12%) patmnts with normal ED prior to treatment 
developed mild aortic regurgitation (AR) during treatment. Out of the 137 
evaluated to date, 27 (20%) demonstrated trace to moderate AR. Abnormally 
bright echoes o~n the aortic valve line at closure were commonly obsarw=d. 
Additionally noted were mild mitral, mild to moderate tricusl~d, and mild 
pulmo~ic VR. 
Conclusions: SigeWaant AR was obse~Bd in 20% of fen/phen - foNmaz 
recipients. The clinical significance, natural history, and need for therapeutic 
inten,,ention desenre careful attenhon. 
• Valvular Abnormalities in Asymptomatic Obese 
Individuals Receiving Fenfluramine and 
Phentermine: A Consecutive Series 
Q.G. Orlandi, D. Price. N. Istfan, R. Davidoff. Boston Unnmrsdy Medical 
Center, Boston. MA. USA 
Background: The combination of fenfluramine and phentermine (F-P) has 
recently been shown to be associated with valvular at!normalities. The in- 
cidence of these abnormalities and the relation to dosage is not known. 
Historic control series have shown that in patients <59 yrs the prevalence of 
trace to mild (1+) mitral regurgitation (MR) is 0% to 34"/0 and that for sortie 
regurgitation tAR) is 0% to 9% The purpose of this study was to assess 
the frequency of valvular abnormalities in a consecutive series of patien~ 
receiving the combination of F-P. 
Methods: Nineteen consecutive, unselected, asymptomatic individuals 
receiving F-P were evaluated with echocardiogrephy. Sixteen were women, 
the mean age was 43 ¢ 10 years and ti~ mean w~ wire 119 ~ ~6kg 
The averago duration of therapy was 10 ~r 5 month~, No ~ had 
cardmc dis~ps~, 
Resufs: Milral valvular ;~,~on'nalitle~ were most common and ~ m 
13 (68%) i;)8t~t~ (pt=.) of wi'mm ~ (42%) llaa ¢har~q~notic mllr~ ¢hofaa} 
or cjffuse mftml valve thlcker~ng m ~ with tho MR, One pL (~%) 
hall read, rat0 MR, eltw~t pt& (&l~.) ha¢l md¢l of ~ MR, ~ pt, iS%) 
had modefat~ AR, fivo ptl, (L~%) ~ mtld of ~ AR, ~ IP~,(1 (~,-_) had 
thiak0~fflg Of tho oof1¢ ~ m ~zso¢14tlt~l with ltto AR 1P~=,%'¢ IP~, (I~P/.) 
ha¢l ~1¢1 Or traoe ~ mguql~tk:m, The~ wa= no ~,em 
tx~',,w,,.'~ ImRth Of therapy and ~ of ~ ,  
F-R T h e ~  lain. ~ wof l ,  #~ Hvtmly Of It~ at~nomt~Iti~, la~ 
nn~ ~ h e s  ~ ~atien~ from no~m~  w~o hS~ ~ 
nom~ valve~ ~n a~me~m v~h ~t ion .  Ck~m~ m ~ t o  
define a ,sk. benofll farm, 
Va lvu la r  Hear t  Surgery  
Monday,  March 30, 1998, 3:00 p .m. -5 :00  p.m. 
Georg ia  World Congress  Center,  West ~l~lb l t  Hall Level 
Presentat ion Hour: 3:00 p.m. -4 :00  p,m, 
~ Chmdal ~ 0o~ Net In f !mm~ t.elt 
Ventri~L=r ~ Fun~lon lmmedlmely 
G-R Green ~ ,P Oagtzm ~ , G.T. Dat~]Mem, II~, N.B. Ingels, Jr?, K.L Yml t , 
D C Miged e..- ,~., ,  a 
• . . o~, , ,  Ur~em~ Slamo~ CA, USA: Palo Alto ~ 
Founda~, PaSo A~ CA, USA 
Bactg~und: Presewat~n cl the mitral ~ubw~vu~ 4~aratus helps maroon 
~eft ~mtnctdar (LV) s01o,ic Vat, on.ante ~ g  MVR for chronic MR, but 
wl~et~ ~ p .~.vat~ i= adva~ for ~ ' tc  tunction m me 
~ po~t~x.al~,e penod I= unclear. 
Met~x~: Eleven ~ ~ Is, t~acotomy aed placem~ ot 
20 rm/ecar~ai ma~ere to asses~ LV volume and w~l stress. Acute MR 
was creatod by p~nc~ong me poster~ zeagm w~h a Cope bm~y nee~ne. 
Altair 12 weeks, MVFI wffh chordal press,Nation was performed, foUowed by 
bq~,a~ v~eo~.,emscor~ stud~ w~ U'te chelae ~ in~act (Cq en~ 
after chordal sevmtng (CS) by Wlm snare. Diastolic function was assessed 
by ~ hme constant and maxrmum ~me denve~e of ~sovelumic pressure 
decay (r.-dP/dt), time constant at ~sovolum¢ wan stress decay (r.), time o! 
tilting ('1"1:), peak filling rate (PFR), and ~me to PFR (TPFR) 
Resu/ts: No statistically significant diffem/',ce:; were obsarvad wh0n all 
c ~  were severed ('Table). 
'[mean ~ SD; P ~ NS I~y ANOVAI 
r' f,,~ V |dP~'t" TF" PFR' TPFR= 
I~) (ms) (mm_l~,s) (ms) (mt, Wrs) Ira.s! . 
MVR-CI 452-.79 44.9±79 -1~t 6~6824 189.2-~43.5 456:1:155 58371"1037 
MVR-CS 476~82 470~82 -15469¢5773 1892±48.3 45.1~:136 5689¢136R 
Corc~us~n: LV diastolic functmn immet~ately fogowing MVR is unaffecte0 
by chordal severing in this carane model of chronic MR. 
~- '~-~ An Encouraging Decade Regurgitation for Mitral 
Surgery 
M.JR. Datrympte-Hey. R A. Jones, M. Bryan', SM. Langley, I.A. Simpson, 
K.D. Dawkins, SA  L~=sey, J.L Monre, Wessex Cardiothoracic Centre, 
Southampton. England 
O0jecf/ve: TO rewew the 10 year experience for mltral regurgitation in one 
UK centre, 
Mettw~: Between 1986 and 199"7, 710 patients with mitrel regurgitation 
underdvent surgery in our unit. (388 males. 3;?2. mean age 63 (7-85). 
Results: The aetiofogy of mitral vahm dysfunction, operative procedure 
and (30 day mortality) am shown below. A miscellaneous group of 23 is not 
shown in the table. 
Operation Degen LE Scheml¢ Rheumat~ 
Ret~iace (atone) 125(1) 46(1) 13|1) 136(7) 
Repair (alone) 127 (0) 8 (0) 4 (0) 6 (0) 
Replace + other 33 (1) 10 (0) 27 (I) 66 (5) 
Repair + other 38 (2) ;'(1) 32 (2) 9 (1) 
Total operative mortality was 30 (42%). Them were no operative deaths 
with mpeir alone. Preoperative NYHA class (P < 0.0003) and regurgifant 
